BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

651 related articles for article (PubMed ID: 34006662)

  • 1. A Generic, Scalable, and Rapid Time-Resolved Förster Resonance Energy Transfer-Based Assay for Antigen Detection-SARS-CoV-2 as a Proof of Concept.
    Rusanen J; Kareinen L; Szirovicza L; Uğurlu H; Levanov L; Jääskeläinen A; Ahava M; Kurkela S; Saksela K; Hedman K; Vapalahti O; Hepojoki J
    mBio; 2021 May; 12(3):. PubMed ID: 34006662
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sensitivity and Specificity of SARS-CoV-2 Rapid Antigen Detection Tests Using Oral, Anterior Nasal, and Nasopharyngeal Swabs: a Diagnostic Accuracy Study.
    Wölfl-Duchek M; Bergmann F; Jorda A; Weber M; Müller M; Seitz T; Zoufaly A; Strassl R; Zeitlinger M; Herkner H; Schnidar H; Anderle K; Derhaschnig U
    Microbiol Spectr; 2022 Feb; 10(1):e0202921. PubMed ID: 35107327
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A 10-Minute "Mix and Read" Antibody Assay for SARS-CoV-2.
    Rusanen J; Kareinen L; Levanov L; Mero S; Pakkanen SH; Kantele A; Amanat F; Krammer F; Hedman K; Vapalahti O; Hepojoki J
    Viruses; 2021 Jan; 13(2):. PubMed ID: 33498157
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Accuracy of a nucleocapsid protein antigen rapid test in the diagnosis of SARS-CoV-2 infection.
    Diao B; Wen K; Zhang J; Chen J; Han C; Chen Y; Wang S; Deng G; Zhou H; Wu Y
    Clin Microbiol Infect; 2021 Feb; 27(2):289.e1-289.e4. PubMed ID: 33031947
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantifying SARS-CoV-2 nucleocapsid antigen in oropharyngeal swabs using single molecule array technology.
    Olsen DA; Brasen CL; Kahns S; Madsen JB; Kierkegaard H; Christensen H; Jensen A; Sydenham TV; Møller JK; Madsen JS; Brandslund I
    Sci Rep; 2021 Oct; 11(1):20323. PubMed ID: 34645907
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison between Nasal and Nasopharyngeal Swabs for SARS-CoV-2 Rapid Antigen Detection in an Asymptomatic Population, and Direct Confirmation by RT-PCR from the Residual Buffer.
    Patriquin G; LeBlanc JJ; Williams C; Hatchette TF; Ross J; Barrett L; Davidson R
    Microbiol Spectr; 2022 Feb; 10(1):e0245521. PubMed ID: 35171010
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Spike vs nucleocapsid SARS-CoV-2 antigen detection: application in nasopharyngeal swab specimens.
    Barlev-Gross M; Weiss S; Ben-Shmuel A; Sittner A; Eden K; Mazuz N; Glinert I; Bar-David E; Puni R; Amit S; Kriger O; Schuster O; Alcalay R; Makdasi E; Epstein E; Noy-Porat T; Rosenfeld R; Achdout H; Mazor O; Israely T; Levy H; Mechaly A
    Anal Bioanal Chem; 2021 May; 413(13):3501-3510. PubMed ID: 33768365
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of Lumipulse® G SARS-CoV-2 antigen assay automated test for detecting SARS-CoV-2 nucleocapsid protein (NP) in nasopharyngeal swabs for community and population screening.
    Gili A; Paggi R; Russo C; Cenci E; Pietrella D; Graziani A; Stracci F; Mencacci A
    Int J Infect Dis; 2021 Apr; 105():391-396. PubMed ID: 33647511
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rapid SARS-CoV-2 antigen detection assay in comparison with real-time RT-PCR assay for laboratory diagnosis of COVID-19 in Thailand.
    Chaimayo C; Kaewnaphan B; Tanlieng N; Athipanyasilp N; Sirijatuphat R; Chayakulkeeree M; Angkasekwinai N; Sutthent R; Puangpunngam N; Tharmviboonsri T; Pongraweewan O; Chuthapisith S; Sirivatanauksorn Y; Kantakamalakul W; Horthongkham N
    Virol J; 2020 Nov; 17(1):177. PubMed ID: 33187528
    [TBL] [Abstract][Full Text] [Related]  

  • 10. On-field evaluation of a ultra-rapid fluorescence immunoassay as a frontline test for SARS-CoV-2 diagnostic.
    Orsi A; Pennati BM; Bruzzone B; Ricucci V; Ferone D; Barbera P; Arboscello E; Dentone C; Icardi G
    J Virol Methods; 2021 Sep; 295():114201. PubMed ID: 34058287
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A high throughput immuno-affinity mass spectrometry method for detection and quantitation of SARS-CoV-2 nucleoprotein in human saliva and its comparison with RT-PCR, RT-LAMP, and lateral flow rapid antigen test.
    Lane D; Allsopp R; Holmes CW; Slingsby OC; Jukes-Jones R; Bird P; Anderson NL; Razavi M; Yip R; Pearson TW; Pope M; Khunti K; Doykov I; Hällqvist J; Mills K; Skipp P; Carling R; Ng L; Shaw J; Gupta P; Jones DJL
    Clin Chem Lab Med; 2024 May; 62(6):1206-1216. PubMed ID: 38253336
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of clinical utility of novel coronavirus antigen detection reagent, Espline® SARS-CoV-2.
    Aoki K; Nagasawa T; Ishii Y; Yagi S; Kashiwagi K; Miyazaki T; Tateda K
    J Infect Chemother; 2021 Feb; 27(2):319-322. PubMed ID: 33388232
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ultrasensitive and Simultaneous Detection of Two Specific SARS-CoV-2 Antigens in Human Specimens Using Direct/Enrichment Dual-Mode Fluorescence Lateral Flow Immunoassay.
    Wang C; Cheng X; Liu L; Zhang X; Yang X; Zheng S; Rong Z; Wang S
    ACS Appl Mater Interfaces; 2021 Sep; 13(34):40342-40353. PubMed ID: 34412466
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative evaluation of RT-PCR and antigen-based rapid diagnostic tests (Ag-RDTs) for SARS-CoV-2 detection: performance, variant specificity, and clinical implications.
    Aboagye FT; Annison L; Hackman HK; Acquah ME; Ashong Y; Owusu-Frimpong I; Egyam BC; Annison S; Osei-Adjei G; Antwi-Baffour S
    Microbiol Spectr; 2024 Jun; 12(6):e0007324. PubMed ID: 38683014
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical assessment of the Roche SARS-CoV-2 rapid antigen test.
    Salvagno GL; Gianfilippi G; Bragantini D; Henry BM; Lippi G
    Diagnosis (Berl); 2021 Aug; 8(3):322-326. PubMed ID: 33554511
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protein-based lateral flow assays for COVID-19 detection.
    Mahmoudinobar F; Britton D; Montclare JK
    Protein Eng Des Sel; 2021 Feb; 34():. PubMed ID: 33991088
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Large scale production and characterization of SARS-CoV-2 whole antigen for serological test development.
    Cerutti H; Ricci V; Tesi G; Soldatini C; Castria M; Vaccaro MN; Tornesi S; Toppi S; Verdiani S; Brogi A
    J Clin Lab Anal; 2021 Apr; 35(4):e23735. PubMed ID: 33608968
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improved diagnosis of SARS-CoV-2 by using nucleoprotein and spike protein fragment 2 in quantitative dual ELISA tests.
    De Marco Verissimo C; O'Brien C; López Corrales J; Dorey A; Cwiklinski K; Lalor R; Doyle JM; Field S; Masterson C; Ribes Martinez E; Hughes G; Bergin C; Walshe K; McNicholas B; Laffey JG; Dalton JP; Kerr C; Doyle S
    Epidemiol Infect; 2021 Jun; 149():e140. PubMed ID: 34099081
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of a quantitative COVID-19 multiplex assay and its use for serological surveillance in a low SARS-CoV-2 incidence community.
    Guarino C; Larson E; Babasyan S; Rollins A; Joshi LR; Laverack M; Parrilla L; Plocharczyk E; Diel DG; Wagner B
    PLoS One; 2022; 17(1):e0262868. PubMed ID: 35061843
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development and Clinical Evaluation of an Immunochromatography-Based Rapid Antigen Test (GenBody™ COVAG025) for COVID-19 Diagnosis.
    Kim D; Lee J; Bal J; Seo SK; Chong CK; Lee JH; Park H
    Viruses; 2021 Apr; 13(5):. PubMed ID: 33946860
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.